Therefore, the primary objective of the current study was to investigate the prevalence and type of incidental changes in lung parenchyma categorized as ILA in patients with HNSCC and their possible alteration following different cancer treatment protocols. The gene discussed is TNFRSF9; the disease is head and neck squamous cell carcinoma.